Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is the evaluation of the efficacy and safety of RPH-104
treatment in patients with recurrent pericarditis.
Pharmacokinetic and pharmacodynamic parameters of RPH-104 multiple doses in this patient
population will be assessed as well.